Complejo Hospitalario Universitario Insular - Materno Infantil de Canarias-ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2020

  1. High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1

    European Journal of Cancer, Vol. 141, pp. 193-198

2019

  1. Efficacy of nintedanib and docetaxel in patients with advanced lung adenocarcinoma treated with first-line chemotherapy and second-line immunotherapy in the nintedanib NPU program

    Clinical and Translational Oncology, Vol. 21, Núm. 9, pp. 1270-1279

  2. Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS): A European Phase II Clinical Trial

    Journal of Thoracic Oncology, Vol. 14, Núm. 7, pp. 1266-1276

2015

  1. SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 1020-1029